These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 16374526)

  • 1. Imaging of a regressive coronary soft plaque under lipid lowering therapy by multi-slice computed tomography.
    Burgstahler C; Reimann A; Beck T; Kuettner A; Heuschmid M; Kopp AF; Schroeder S
    Int J Cardiovasc Imaging; 2006 Feb; 22(1):119-21. PubMed ID: 16374526
    [No Abstract]   [Full Text] [Related]  

  • 2. Dramatic regression of three-vessel disease under statin treatment in patients with stable angina pectoris.
    Ercan S; Sari I; Davutoglu V
    Ther Adv Cardiovasc Dis; 2012 Dec; 6(6):259-60. PubMed ID: 23196941
    [No Abstract]   [Full Text] [Related]  

  • 3. Intensive lipid-lowering therapy ameliorates novel calcification markers and GSM score in patients with carotid stenosis.
    Kadoglou NP; Gerasimidis T; Moumtzouoglou A; Kapelouzou A; Sailer N; Fotiadis G; Vitta I; Katinios A; Kougias P; Bandios S; Voliotis K; Karayannacos PE; Liapis CD
    Eur J Vasc Endovasc Surg; 2008 Jun; 35(6):661-8. PubMed ID: 18395477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular computed tomographic assessment of the effect of combination lipoprotein therapy on coronary arterial plaque: rationale and design of the AFRICA (Atorvastatin plus Fenofibric acid in the Reduction of Intermediate Coronary Atherosclerosis) study.
    Voros S; Joshi PH; Vazquez G; Roth G; Murrieta L; Rinehart S; Qian Z; Miller J
    J Cardiovasc Comput Tomogr; 2010; 4(3):164-72. PubMed ID: 20413364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of atorvastatin on carotid atherosclerotic plaques: a randomized trial for quantitative tissue characterization of carotid atherosclerotic plaques with integrated backscatter ultrasound.
    Yamada K; Yoshimura S; Kawasaki M; Enomoto Y; Asano T; Minatoguchi S; Iwama T
    Cerebrovasc Dis; 2009; 28(4):417-24. PubMed ID: 19707015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial changes of serum calcification markers and contralateral carotid plaques echogenicity after combined carotid artery stenting plus intensive lipid-lowering therapy in patients with bilateral carotid stenosis.
    Kadoglou NP; Gerasimidis T; Kapelouzou A; Moumtzouoglou A; Avgerinos ED; Kakisis JD; Karayannacos PE; Liapis CD
    Eur J Vasc Endovasc Surg; 2010 Mar; 39(3):258-65. PubMed ID: 20004120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torcetrapib and atorvastatin.
    Shear CL
    N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
    [No Abstract]   [Full Text] [Related]  

  • 9. Atorvastatin and fibrinogen--a small subgroup shows extreme response.
    Sinzinger H; Rodrigues M
    Atherosclerosis; 1999 Aug; 145(2):415-7. PubMed ID: 10488971
    [No Abstract]   [Full Text] [Related]  

  • 10. Profound regression of coronary atherosclerosis with statins.
    Abdallah MH; Karrowni W; Dakik HA
    Can J Cardiol; 2006 Jun; 22(8):709. PubMed ID: 16802002
    [No Abstract]   [Full Text] [Related]  

  • 11. Statin therapy for subclinical atherosclerosis in primary prevention: time to prove it?
    Villines TC
    JACC Cardiovasc Imaging; 2012 Mar; 5(3):261-3. PubMed ID: 22421170
    [No Abstract]   [Full Text] [Related]  

  • 12. [First comparison of 2 statins shows: only radical LDL lowering stops coronary atherosclerosis].
    Einecke D
    MMW Fortschr Med; 2003 Dec; 145(51-52):38. PubMed ID: 14974329
    [No Abstract]   [Full Text] [Related]  

  • 13. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K
    Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
    [No Abstract]   [Full Text] [Related]  

  • 14. The relationship between nonalcoholic fatty liver disease and the severity of coronary artery disease in patients with metabolic syndrome.
    Uzun M; Yiğiner O; Kirilmaz A
    Turk Kardiyol Dern Ars; 2009 Jul; 37(5):364; author reply 365. PubMed ID: 19875919
    [No Abstract]   [Full Text] [Related]  

  • 15. Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization.
    Kadoglou NP; Sailer N; Moumtzouoglou A; Kapelouzou A; Gerasimidis T; Liapis CD
    J Vasc Surg; 2010 Jan; 51(1):114-21. PubMed ID: 19837545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid-lowering medications: what the new guidelines and data mean to women.
    Schwartz JB
    J Gend Specif Med; 2001; 4(2):9-13. PubMed ID: 11480105
    [No Abstract]   [Full Text] [Related]  

  • 17. Targeting specific traditional risk factors to improve cardiovascular outcomes: Sound or flawed?
    Yeboah J
    Atherosclerosis; 2013 Feb; 226(2):335-6. PubMed ID: 23153621
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive coronary calcification despite intensive lipid-lowering treatment: a randomised controlled trial.
    Houslay ES; Cowell SJ; Prescott RJ; Reid J; Burton J; Northridge DB; Boon NA; Newby DE;
    Heart; 2006 Sep; 92(9):1207-12. PubMed ID: 16449511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised determination of the Effect of Fluvastatin and Atorvastatin on top of dual antiplatelet treatment on platelet aggregation after implantation of coronary drug-eluting stents. The EFA-Trial.
    Wenaweser P; Eshtehardi P; Abrecht L; Zwahlen M; Schmidlin K; Windecker S; Meier B; Haeberli A; Hess OM
    Thromb Haemost; 2010 Sep; 104(3):554-62. PubMed ID: 20664903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease.
    Nidorf M; Thompson PL
    Am J Cardiol; 2007 Mar; 99(6):805-7. PubMed ID: 17350370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.